Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk

被引:281
|
作者
King, Valencia [1 ]
Brooks, Jennifer D. [2 ]
Bernstein, Jonine L. [2 ]
Reiner, Anne S. [2 ]
Pike, Malcolm C. [2 ]
Morris, Elizabeth A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
关键词
HORMONE REPLACEMENT THERAPY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC FEATURES; MENSTRUAL-CYCLE; TISSUE; DENSITY; WOMEN; PATTERNS; CLASSIFICATION; AGE;
D O I
10.1148/radiol.11102156
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging. Materials and Methods: A waiver of authorization was granted by the institutional review board for this retrospective HIPAA-compliant study. Among 1275 women who underwent breast MR imaging screening between December 2002 and February 2008, 39 breast carcinoma cases were identified. Two comparisons were performed: In one comparison, two normal controls-those of the women with negative (benign) findings at breast MR imaging-were matched to each breast cancer case on the basis of age and date of MR imaging. In the second comparison, one false-positive control-that of a woman with suspicious but nonmalignant findings at MR imaging-was similarly matched to each breast cancer case. Two readers independently rated the level of MR imaging-depicted BPE and the amount of MR imaging-depicted FGT by using a categorical scale: BPE was categorized as minimal, mild, moderate, or marked, and FGT was categorized as fatty, scattered, heterogeneously dense, or dense. Results: Compared with the odds ratio (OR) for a normal control, the OR for breast cancer increased significantly with increasing BPE: The ORs for moderate or marked BPE versus minimal or mild BPE were 10.1 (95% confidence interval [CI]: 2.9, 35.3; P < .001) and 3.3 (95% CI: 1.3, 8.3; P = .006) for readers 1 and 2, respectively. Similar odds were seen when the false-positive controls were compared with the breast cancer cases: The ORs for moderate or marked BPE versus minimal or mild BPE were 5.1 (95% CI: 1.4, 19.1; P = .005) and 3.7 (95% CI: 1.2, 11.2; P = .013) for readers 1 and 2, respectively. The breast cancer odds also increased with increasing FGT, but the BPE findings remained significant after adjustment for FGT. Conclusion: Increased BPE is strongly predictive of breast cancer odds. (C) RSNA, 2011
引用
收藏
页码:50 / 60
页数:11
相关论文
共 50 条
  • [21] Background Parenchymal Enhancement at Postoperative Surveillance Breast MRI: Association with Future Second Breast Cancer Risk
    Lee, Su Hyun
    Jang, Myoung-jin
    Yoen, Heera
    Lee, Youkyoung
    Kim, Yeon Soo
    Park, Ah Reum
    Ha, Su Min
    Kim, Soo-Yeon
    Chang, Jung Min
    Cho, Nariya
    Moon, Woo Kyung
    RADIOLOGY, 2023, 306 (01) : 90 - 99
  • [22] Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
    Hu, Xiaoxin
    Jiang, Luan
    Li, Qiang
    Gu, Yajia
    ONCOTARGET, 2017, 8 (06) : 10620 - 10627
  • [23] Analysis of background parenchymal echogenicity on breast ultrasound Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
    Ko, Kyung Hee
    Jung, Hae Kyoung
    Kim, Inwha
    MEDICINE, 2017, 96 (33)
  • [24] Is Background Parenchymal Enhancement an Important Risk Factor for Breast Cancer Development in Women with Increased Risk?
    Mann, Ritse M.
    Pinker, Katja
    RADIOLOGY, 2019, 292 (03) : 562 - 563
  • [25] Editorial Comment on "Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study"
    Dibble, Elizabeth H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 216 (05) : 1204 - 1204
  • [26] Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices
    Ray, Kimberly M.
    Kerlikowske, Karla
    Lobach, Iryna V.
    Hofmann, Michael B.
    Greenwood, Heather I.
    Arasu, Vignesh A.
    Hylton, Nola M.
    Joe, Bonnie N.
    RADIOLOGY, 2018, 286 (03) : 822 - 829
  • [27] Possible Breast Cancer Risk Related to Background Parenchymal Enhancement at Breast MRI: A Meta-Analysis Study
    Zhang, Hui
    Guo, Lili
    Tao, Weijing
    Zhang, Jiandong
    Zhu, Yan
    Abdelrahim, Mohamed E. A.
    Bai, Genji
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (08): : 1371 - 1377
  • [28] Impact of Radiotherapy on Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging
    Kim, Yun Ju
    Kim, Sung Hun
    Choi, Byung Gil
    Kang, Bong Joo
    Kim, Hyeon Sook
    Cha, Eun Suk
    Song, Byung Joo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 2939 - 2943
  • [29] A background parenchymal enhancement quantification framework of breast magnetic resonance imaging
    Zhang, Boya
    Zhu, Jingjin
    Zhang, Peifang
    Wei, Yufan
    Li, Yan
    Xu, Aoxi
    Zhang, Yiheng
    Zheng, Hongye
    Dong, Xiaohan
    Yang, Kaizhou
    Dong, Chuang
    Chen, Zhengming
    Li, Xiru
    Cheng, Liuquan
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (12) : 8350 - +
  • [30] Background parenchymal enhancement (BPE) on breast magnetic resonance imaging as a biomarker of breast cancer risk among BRCA1/2 carriers
    McCarthy, Anne Marie
    Nguyen, Alex Anh-Tu
    Mankowski, Walter
    Cohen, Eric
    Ehsan, Sarah
    Gillette, Rhonda
    Pantalone, Lauren
    Weinstein, Susan
    Conant, Emily
    Domchek, Susan
    Kontos, Despina
    CANCER RESEARCH, 2024, 84 (09)